• レポートコード:QAF27922 • 出版社/出版日:QYResearch / 2021年3月31日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、135ページ • 納品方法:Eメール(即日納品) • 産業分類:医薬品 |
Single User | ¥600,000 (USD4,000) | ▷ お問い合わせ |
Multi User | ¥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本市場調査資料では、世界のウロキナーゼ市場について種類別(ウロキナーゼ粉末、ウロキナーゼ溶液)、用途別(病院、診療所、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ウロキナーゼ市場の概要 ・世界の主要地域別ウロキナーゼ市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のウロキナーゼ市場規模2016-2021:種類別(ウロキナーゼ粉末、ウロキナーゼ溶液) ・世界のウロキナーゼ市場予測2012-2027:種類別(ウロキナーゼ粉末、ウロキナーゼ溶液) ・世界のウロキナーゼ市場規模2016-2021:用途別(病院、診療所、その他) ・世界のウロキナーゼ市場予測2012-2027:用途別(病院、診療所、その他) ・ウロキナーゼのアメリカ市場規模と予測2016-2021 ・ウロキナーゼのヨーロッパ市場規模と予測2016-2021 ・ウロキナーゼの中国市場規模と予測2016-2021 ・ウロキナーゼの日本市場規模と予測2016-2021 ・ウロキナーゼの東南アジア市場規模と予測2016-2021 ・ウロキナーゼのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報:事業概要・売上・企業動向 (NDPHARM、Wanhua Biochem、Jiangxi Haoran Bio-Pharma、Jiangsu Aidea Pharmaceutical、Techpool、Microbic Biosystems Inc、LIVZON) ・ウロキナーゼの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ウロキナーゼの市場動向・機会・課題 ・調査の結論 |
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Major players in the industry are NDPHARM, Wanhua Biochem and LIVZON, which accounted for 22.35 percent, 10.11 percent and 21.86 percent of revenue in 2019, respectively. According to the region, China’s income is the highest, reaching 82.57% in 2019.
Market Analysis and Insights: Global Urokinase Market
The global Urokinase market was valued at US$ 42 in 2020 and will reach US$ 59 million by the end of 2027, growing at a CAGR of 6.1% during 2022-2027.
Global Urokinase Scope and Market Size
The global Urokinase market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Urokinase market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Urokinase Powder
Urokinase Solution
Urokinase powder captures about 92.27% of urokinase revenue market in 2019.
Segment by Application
Hospital
Clinic
Others
Hospital accounts for nearly 80% of total consumption of urokinase in global in 2019.
The Urokinase market is analysed and market size information is provided by regions (countries). Segment by Application, the Urokinase market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
NDPHARM
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Techpool
Microbic Biosystems Inc
LIVZON
1 Urokinase Market Overview
1.1 Urokinase Product Scope
1.2 Urokinase Segment by Type
1.2.1 Global Urokinase Sales by Type (2016 & 2021 & 2027)
1.2.2 Urokinase Powder
1.2.3 Urokinase Solution
1.3 Urokinase Segment by Application
1.3.1 Global Urokinase Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Urokinase Market Estimates and Forecasts (2016-2027)
1.4.1 Global Urokinase Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Urokinase Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Urokinase Price Trends (2016-2027)
2 Urokinase Estimates and Forecasts by Region
2.1 Global Urokinase Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Urokinase Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Urokinase Sales Market Share by Region (2016-2021)
2.2.2 Global Urokinase Revenue Market Share by Region (2016-2021)
2.3 Global Urokinase Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Urokinase Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Urokinase Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Urokinase Estimates and Projections (2016-2027)
2.4.2 Europe Urokinase Estimates and Projections (2016-2027)
2.4.3 China Urokinase Estimates and Projections (2016-2027)
2.4.4 Japan Urokinase Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Urokinase Estimates and Projections (2016-2027)
2.4.6 India Urokinase Estimates and Projections (2016-2027)
3 Global Urokinase Competition Landscape by Players
3.1 Global Top Urokinase Players by Sales (2016-2021)
3.2 Global Top Urokinase Players by Revenue (2016-2021)
3.3 Global Urokinase Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Urokinase as of 2020)
3.4 Global Urokinase Average Price by Company (2016-2021)
3.5 Manufacturers Urokinase Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Urokinase Market Size by Type
4.1 Global Urokinase Historic Market Review by Type (2016-2021)
4.1.1 Global Urokinase Sales Market Share by Type (2016-2021)
4.1.2 Global Urokinase Revenue Market Share by Type (2016-2021)
4.1.3 Global Urokinase Price by Type (2016-2021)
4.2 Global Urokinase Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Urokinase Sales Forecast by Type (2022-2027)
4.2.2 Global Urokinase Revenue Forecast by Type (2022-2027)
4.2.3 Global Urokinase Price Forecast by Type (2022-2027)
5 Global Urokinase Market Size by Application
5.1 Global Urokinase Historic Market Review by Application (2016-2021)
5.1.1 Global Urokinase Sales Market Share by Application (2016-2021)
5.1.2 Global Urokinase Revenue Market Share by Application (2016-2021)
5.1.3 Global Urokinase Price by Application (2016-2021)
5.2 Global Urokinase Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Urokinase Sales Forecast by Application (2022-2027)
5.2.2 Global Urokinase Revenue Forecast by Application (2022-2027)
5.2.3 Global Urokinase Price Forecast by Application (2022-2027)
6 North America Urokinase Market Facts & Figures
6.1 North America Urokinase Sales by Company
6.1.1 North America Urokinase Sales by Company (2016-2021)
6.1.2 North America Urokinase Revenue by Company (2016-2021)
6.2 North America Urokinase Sales Breakdown by Type
6.2.1 North America Urokinase Sales Breakdown by Type (2016-2021)
6.2.2 North America Urokinase Sales Breakdown by Type (2022-2027)
6.3 North America Urokinase Sales Breakdown by Application
6.3.1 North America Urokinase Sales Breakdown by Application (2016-2021)
6.3.2 North America Urokinase Sales Breakdown by Application (2022-2027)
7 Europe Urokinase Market Facts & Figures
7.1 Europe Urokinase Sales by Company
7.1.1 Europe Urokinase Sales by Company (2016-2021)
7.1.2 Europe Urokinase Revenue by Company (2016-2021)
7.2 Europe Urokinase Sales Breakdown by Type
7.2.1 Europe Urokinase Sales Breakdown by Type (2016-2021)
7.2.2 Europe Urokinase Sales Breakdown by Type (2022-2027)
7.3 Europe Urokinase Sales Breakdown by Application
7.3.1 Europe 135 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 135 Sales Breakdown by Application (2022-2027)
8 China Urokinase Market Facts & Figures
8.1 China Urokinase Sales by Company
8.1.1 China Urokinase Sales by Company (2016-2021)
8.1.2 China Urokinase Revenue by Company (2016-2021)
8.2 China Urokinase Sales Breakdown by Type
8.2.1 China Urokinase Sales Breakdown by Type (2016-2021)
8.2.2 China Urokinase Sales Breakdown by Type (2022-2027)
8.3 China Urokinase Sales Breakdown by Application
8.3.1 China 241 Sales Breakdown by Application (2016-2021)
8.3.2 China 241 Sales Breakdown by Application (2022-2027)
9 Japan Urokinase Market Facts & Figures
9.1 Japan Urokinase Sales by Company
9.1.1 Japan Urokinase Sales by Company (2016-2021)
9.1.2 Japan Urokinase Revenue by Company (2016-2021)
9.2 Japan Urokinase Sales Breakdown by Type
9.2.1 Japan Urokinase Sales Breakdown by Type (2016-2021)
9.2.2 Japan Urokinase Sales Breakdown by Type (2022-2027)
9.3 Japan Urokinase Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Urokinase Market Facts & Figures
10.1 Southeast Asia Urokinase Sales by Company
10.1.1 Southeast Asia Urokinase Sales by Company (2016-2021)
10.1.2 Southeast Asia Urokinase Revenue by Company (2016-2021)
10.2 Southeast Asia Urokinase Sales Breakdown by Type
10.2.1 Southeast Asia Urokinase Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Urokinase Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Urokinase Sales Breakdown by Application
10.3.1 Southeast Asia MIU Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia MIU Sales Breakdown by Application (2022-2027)
11 India Urokinase Market Facts & Figures
11.1 India Urokinase Sales by Company
11.1.1 India Urokinase Sales by Company (2016-2021)
11.1.2 India Urokinase Revenue by Company (2016-2021)
11.2 India Urokinase Sales Breakdown by Type
11.2.1 India Urokinase Sales Breakdown by Type (2016-2021)
11.2.2 India Urokinase Sales Breakdown by Type (2022-2027)
11.3 India Urokinase Sales Breakdown by Application
11.3.1 India Urokinase Sales Breakdown by Application (2016-2021)
11.3.2 India Urokinase Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Urokinase Business
12.1 NDPHARM
12.1.1 NDPHARM Corporation Information
12.1.2 NDPHARM Business Overview
12.1.3 NDPHARM Urokinase Sales, Revenue and Gross Margin (2016-2021)
12.1.4 NDPHARM Urokinase Products Offered
12.1.5 NDPHARM Recent Development
12.2 Wanhua Biochem
12.2.1 Wanhua Biochem Corporation Information
12.2.2 Wanhua Biochem Business Overview
12.2.3 Wanhua Biochem Urokinase Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Wanhua Biochem Urokinase Products Offered
12.2.5 Wanhua Biochem Recent Development
12.3 Jiangxi Haoran Bio-Pharma
12.3.1 Jiangxi Haoran Bio-Pharma Corporation Information
12.3.2 Jiangxi Haoran Bio-Pharma Business Overview
12.3.3 Jiangxi Haoran Bio-Pharma Urokinase Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Jiangxi Haoran Bio-Pharma Urokinase Products Offered
12.3.5 Jiangxi Haoran Bio-Pharma Recent Development
12.4 Jiangsu Aidea Pharmaceutical
12.4.1 Jiangsu Aidea Pharmaceutical Corporation Information
12.4.2 Jiangsu Aidea Pharmaceutical Business Overview
12.4.3 Jiangsu Aidea Pharmaceutical Urokinase Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Jiangsu Aidea Pharmaceutical Urokinase Products Offered
12.4.5 Jiangsu Aidea Pharmaceutical Recent Development
12.5 Techpool
12.5.1 Techpool Corporation Information
12.5.2 Techpool Business Overview
12.5.3 Techpool Urokinase Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Techpool Urokinase Products Offered
12.5.5 Techpool Recent Development
12.6 Microbic Biosystems Inc
12.6.1 Microbic Biosystems Inc Corporation Information
12.6.2 Microbic Biosystems Inc Business Overview
12.6.3 Microbic Biosystems Inc Urokinase Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Microbic Biosystems Inc Urokinase Products Offered
12.6.5 Microbic Biosystems Inc Recent Development
12.7 LIVZON
12.7.1 LIVZON Corporation Information
12.7.2 LIVZON Business Overview
12.7.3 LIVZON Urokinase Sales, Revenue and Gross Margin (2016-2021)
12.7.4 LIVZON Urokinase Products Offered
12.7.5 LIVZON Recent Development
…
13 Urokinase Manufacturing Cost Analysis
13.1 Urokinase Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Urokinase
13.4 Urokinase Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Urokinase Distributors List
14.3 Urokinase Customers
15 Market Dynamics
15.1 Urokinase Market Trends
15.2 Urokinase Drivers
15.3 Urokinase Market Challenges
15.4 Urokinase Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Urokinase Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Urokinase Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Urokinase Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Urokinase Sales (MIU) by Region (2016-2021)
Table 5. Global Urokinase Sales Market Share by Region (2016-2021)
Table 6. Global Urokinase Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Urokinase Revenue Share by Region (2016-2021)
Table 8. Global Urokinase Sales (MIU) Forecast by Region (2022-2027)
Table 9. Global Urokinase Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Urokinase Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Urokinase Revenue Share Forecast by Region (2022-2027)
Table 12. Global Urokinase Sales (MIU) of Key Companies (2016-2021)
Table 13. Global Urokinase Sales Share by Company (2016-2021)
Table 14. Global Urokinase Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Urokinase Revenue Share by Company (2016-2021)
Table 16. Global Urokinase by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urokinase as of 2020)
Table 17. Global Urokinase Average Price (US$/MIU) of Key Company (2016-2021)
Table 18. Manufacturers Urokinase Manufacturing Sites and Area Served
Table 19. Manufacturers Urokinase Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Urokinase Sales (MIU) by Type (2016-2021)
Table 22. Global Urokinase Sales Share by Type (2016-2021)
Table 23. Global Urokinase Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Urokinase Price (US$/MIU) by Type (2016-2021)
Table 25. Global Urokinase Sales Share by Type (2022-2027)
Table 26. Global Urokinase Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Urokinase Revenue Share by Type (2022-2027)
Table 28. Global Urokinase Price (US$/MIU) by Type (2022-2027)
Table 29. Global Urokinase Sales (MIU) by Application (2016-2021)
Table 30. Global Urokinase Sales Share by Application (2016-2021)
Table 31. Global Urokinase Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Urokinase Price (US$/MIU) by Application (2016-2021)
Table 33. Global Urokinase Sales (MIU) by Application (2022-2027)
Table 34. Global Urokinase Sales Share by Application (2022-2027)
Table 35. Global Urokinase Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Urokinase Revenue Share by Application (2022-2027)
Table 37. Global Urokinase Price (US$/MIU) by Application (2022-2027)
Table 38. North America Urokinase Sales (MIU) by Company (2016-2021)
Table 39. North America Urokinase Sales Market Share by Company (2016-2021)
Table 40. North America Urokinase Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Urokinase Revenue Market Share by Company (2016-2021)
Table 42. North America Urokinase Sales by Type (2016-2021) & (MIU)
Table 43. North America Urokinase Sales Market Share by Type (2016-2021)
Table 44. North America Urokinase Sales by Type (2022-2027) & (MIU)
Table 45. North America Urokinase Sales Market Share by Type (2022-2027)
Table 46. North America Urokinase Sales by Application (2016-2021) & (MIU)
Table 47. North America Urokinase Sales Market Share by Application (2016-2021)
Table 48. North America Urokinase Sales by Application (2022-2027) & (MIU)
Table 49. North America Urokinase Sales Market Share by Application (2022-2027)
Table 50. Europe Urokinase Sales (MIU) by Company (2016-2021)
Table 51. Europe Urokinase Sales Market Share by Company (2016-2021)
Table 52. Europe Urokinase Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Urokinase Revenue Market Share by Company (2016-2021)
Table 54. Europe Urokinase Sales by Type (2016-2021) & (MIU)
Table 55. Europe Urokinase Sales Market Share by Type (2016-2021)
Table 56. Europe Urokinase Sales by Type (2022-2027) & (MIU)
Table 57. Europe Urokinase Sales Market Share by Type (2022-2027)
Table 58. Europe Urokinase Sales by Application (2016-2021) & (MIU)
Table 59. Europe Urokinase Sales Market Share by Application (2016-2021)
Table 60. Europe Urokinase Sales by Application (2022-2027) & (MIU)
Table 61. Europe Urokinase Sales Market Share by Application (2022-2027)
Table 62. China Urokinase Sales (MIU) by Company (2016-2021)
Table 63. China Urokinase Sales Market Share by Company (2016-2021)
Table 64. China Urokinase Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Urokinase Revenue Market Share by Company (2016-2021)
Table 66. China Urokinase Sales by Type (2016-2021) & (MIU)
Table 67. China Urokinase Sales Market Share by Type (2016-2021)
Table 68. China Urokinase Sales by Type (2022-2027) & (MIU)
Table 69. China Urokinase Sales Market Share by Type (2022-2027)
Table 70. China Urokinase Sales by Application (2016-2021) & (MIU)
Table 71. China Urokinase Sales Market Share by Application (2016-2021)
Table 72. China Urokinase Sales by Application (2022-2027) & (MIU)
Table 73. China Urokinase Sales Market Share by Application (2022-2027)
Table 74. Japan Urokinase Sales (MIU) by Company (2016-2021)
Table 75. Japan Urokinase Sales Market Share by Company (2016-2021)
Table 76. Japan Urokinase Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Urokinase Revenue Market Share by Company (2016-2021)
Table 78. Japan Urokinase Sales by Type (2016-2021) & (MIU)
Table 79. Japan Urokinase Sales Market Share by Type (2016-2021)
Table 80. Japan Urokinase Sales by Type (2022-2027) & (MIU)
Table 81. Japan Urokinase Sales Market Share by Type (2022-2027)
Table 82. Japan Urokinase Sales by Application (2016-2021) & (MIU)
Table 83. Japan Urokinase Sales Market Share by Application (2016-2021)
Table 84. Japan Urokinase Sales by Application (2022-2027) & (MIU)
Table 85. Japan Urokinase Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Urokinase Sales (MIU) by Company (2016-2021)
Table 87. Southeast Asia Urokinase Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Urokinase Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Urokinase Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Urokinase Sales by Type (2016-2021) & (MIU)
Table 91. Southeast Asia Urokinase Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Urokinase Sales by Type (2022-2027) & (MIU)
Table 93. Southeast Asia Urokinase Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Urokinase Sales by Application (2016-2021) & (MIU)
Table 95. Southeast Asia Urokinase Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Urokinase Sales by Application (2022-2027) & (MIU)
Table 97. Southeast Asia Urokinase Sales Market Share by Application (2022-2027)
Table 98. India Urokinase Sales (MIU) by Company (2016-2021)
Table 99. India Urokinase Sales Market Share by Company (2016-2021)
Table 100. India Urokinase Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Urokinase Revenue Market Share by Company (2016-2021)
Table 102. India Urokinase Sales by Type (2016-2021) & (MIU)
Table 103. India Urokinase Sales Market Share by Type (2016-2021)
Table 104. India Urokinase Sales by Type (2022-2027) & (MIU)
Table 105. India Urokinase Sales Market Share by Type (2022-2027)
Table 106. India Urokinase Sales by Application (2016-2021) & (MIU)
Table 107. India Urokinase Sales Market Share by Application (2016-2021)
Table 108. India Urokinase Sales by Application (2022-2027) & (MIU)
Table 109. India Urokinase Sales Market Share by Application (2022-2027)
Table 110. NDPHARM Corporation Information
Table 111. NDPHARM Description and Business Overview
Table 112. NDPHARM Urokinase Sales (MIU), Revenue (Million USD), Price (US$/MIU) and Gross Margin (2016-2021)
Table 113. NDPHARM Urokinase Product
Table 114. NDPHARM Recent Development
Table 115. Wanhua Biochem Corporation Information
Table 116. Wanhua Biochem Description and Business Overview
Table 117. Wanhua Biochem Urokinase Sales (MIU), Revenue (Million USD), Price (US$/MIU) and Gross Margin (2016-2021)
Table 118. Wanhua Biochem Urokinase Product
Table 119. Wanhua Biochem Recent Development
Table 120. Jiangxi Haoran Bio-Pharma Corporation Information
Table 121. Jiangxi Haoran Bio-Pharma Description and Business Overview
Table 122. Jiangxi Haoran Bio-Pharma Urokinase Sales (MIU), Revenue (Million USD), Price (US$/MIU) and Gross Margin (2016-2021)
Table 123. Jiangxi Haoran Bio-Pharma Urokinase Product
Table 124. Jiangxi Haoran Bio-Pharma Recent Development
Table 125. Jiangsu Aidea Pharmaceutical Corporation Information
Table 126. Jiangsu Aidea Pharmaceutical Description and Business Overview
Table 127. Jiangsu Aidea Pharmaceutical Urokinase Sales (MIU), Revenue (Million USD), Price (US$/MIU) and Gross Margin (2016-2021)
Table 128. Jiangsu Aidea Pharmaceutical Urokinase Product
Table 129. Jiangsu Aidea Pharmaceutical Recent Development
Table 130. Techpool Corporation Information
Table 131. Techpool Description and Business Overview
Table 132. Techpool Urokinase Sales (MIU), Revenue (Million USD), Price (US$/MIU) and Gross Margin (2016-2021)
Table 133. Techpool Urokinase Product
Table 134. Techpool Recent Development
Table 135. Microbic Biosystems Inc Corporation Information
Table 136. Microbic Biosystems Inc Description and Business Overview
Table 137. Microbic Biosystems Inc Urokinase Sales (MIU), Revenue (Million USD), Price (US$/MIU) and Gross Margin (2016-2021)
Table 138. Microbic Biosystems Inc Urokinase Product
Table 139. Microbic Biosystems Inc Recent Development
Table 140. LIVZON Corporation Information
Table 141. LIVZON Description and Business Overview
Table 142. LIVZON Urokinase Sales (MIU), Revenue (Million USD), Price (US$/MIU) and Gross Margin (2016-2021)
Table 143. LIVZON Urokinase Product
Table 144. LIVZON Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Urokinase Distributors List
Table 148. Urokinase Customers List
Table 149. Urokinase Market Trends
Table 150. Urokinase Market Drivers
Table 151. Urokinase Market Challenges
Table 152. Urokinase Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Urokinase Product Picture
Figure 2. Global Urokinase Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Urokinase Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Others Examples
Figure 9. Global Urokinase Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Urokinase Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Urokinase Sales (MIU) Growth Rate (2016-2027)
Figure 12. Global Urokinase Price Trends Growth Rate (2016-2027) (US$/MIU)
Figure 13. Global Urokinase Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Urokinase Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Urokinase Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Urokinase Sales (MIU) Growth Rate (2016-2027)
Figure 17. Europe Urokinase Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Urokinase Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Urokinase Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Urokinase Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Urokinase Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Urokinase Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Urokinase Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Urokinase Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Urokinase Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Urokinase Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Urokinase Players Market Share by Revenue in Urokinase: 2016 & 2020
Figure 28. Urokinase Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Urokinase Revenue Share by Type (2016-2021)
Figure 30. Global Urokinase Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Urokinase Revenue Share by Application (2016-2021)
Figure 32. Global Urokinase Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Urokinase Sales Market Share by Type in 2020
Figure 34. North America Urokinase Sales Market Share by Application in 2020
Figure 35. Europe Urokinase Sales Market Share by Type in 2020
Figure 36. Europe Urokinase Sales Market Share by Application in 2020
Figure 37. China Urokinase Sales Market Share by Type in 2020
Figure 38. China Urokinase Sales Market Share by Application in 2020
Figure 39. Japan Urokinase Sales Market Share by Type in 2020
Figure 40. Japan Urokinase Sales Market Share by Application in 2020
Figure 41. Southeast Asia Urokinase Sales Market Share by Type in 2020
Figure 42. Southeast Asia Urokinase Sales Market Share by Application in 2020
Figure 43. India Urokinase Sales Market Share by Type in 2020
Figure 44. India Urokinase Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Urokinase
Figure 47. Manufacturing Process Analysis of Urokinase
Figure 48. Urokinase Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed